A Study of LY3076226 in Participants With Advanced or Metastatic Cancer
Clinical trial NCT02529553 · COMPLETED
Trial details
- NCT number
- NCT02529553
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2018-03-28
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.